(Total Views: 495)
Posted On: 06/03/2019 4:14:02 PM
Post# of 154960
I’m curious of the medical minds on their interpretation of the recent article about CCR5 deletion causing earlier deaths.
https://www.theguardian.com/science/2019/jun/...arly-death
My initial take is it may be positive for leronlimab as it may discourage or slow CAR-T treatments or approval that delete CCR5.......and I understand that with leronlimab it helps promote or activate the body’s own immune response (which is believed to be the cause of the early deaths for this small delta 32 population).
https://www.theguardian.com/science/2019/jun/...arly-death
My initial take is it may be positive for leronlimab as it may discourage or slow CAR-T treatments or approval that delete CCR5.......and I understand that with leronlimab it helps promote or activate the body’s own immune response (which is believed to be the cause of the early deaths for this small delta 32 population).
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
